Epithelial-mesenchymal transition (EMT) is a critical process in tissue development and disease, including fibrosis. This review discusses recent advances in EMT signaling in health and disease, highlighting its role in fibroblast generation during organ fibrosis. EMT involves the transformation of epithelial cells into mesenchymal cells, which can lead to fibrosis and cancer metastasis. The process is regulated by various signaling pathways, including TGF-β, EGF, IGF-II, and FGF-2, which induce EMT by altering cell adhesion, cytoskeletal structure, and gene expression. EMT is also involved in the genesis of fibroblasts during kidney fibrosis, with a significant proportion of fibroblasts originating from tubular epithelia. The EMT process is complex, involving molecular reprogramming and interactions between epithelial and stromal cells. Recent studies suggest that EMT can be reversed or attenuated by specific cytokines and growth factors, such as BMP-7, which counteracts TGF-β-induced EMT. Fibroblasts can also arise from local EMT or bone marrow. The EMT process is essential for tissue repair and development but can contribute to disease progression. Understanding the mechanisms of EMT is crucial for developing therapeutic strategies to combat fibrosis and cancer metastasis. The review also discusses the role of various signaling pathways, including Ras, Rho, and Smad, in regulating EMT and the implications of EMT in fibrosis and cancer. Overall, EMT is a dynamic process that plays a critical role in tissue development, repair, and disease.Epithelial-mesenchymal transition (EMT) is a critical process in tissue development and disease, including fibrosis. This review discusses recent advances in EMT signaling in health and disease, highlighting its role in fibroblast generation during organ fibrosis. EMT involves the transformation of epithelial cells into mesenchymal cells, which can lead to fibrosis and cancer metastasis. The process is regulated by various signaling pathways, including TGF-β, EGF, IGF-II, and FGF-2, which induce EMT by altering cell adhesion, cytoskeletal structure, and gene expression. EMT is also involved in the genesis of fibroblasts during kidney fibrosis, with a significant proportion of fibroblasts originating from tubular epithelia. The EMT process is complex, involving molecular reprogramming and interactions between epithelial and stromal cells. Recent studies suggest that EMT can be reversed or attenuated by specific cytokines and growth factors, such as BMP-7, which counteracts TGF-β-induced EMT. Fibroblasts can also arise from local EMT or bone marrow. The EMT process is essential for tissue repair and development but can contribute to disease progression. Understanding the mechanisms of EMT is crucial for developing therapeutic strategies to combat fibrosis and cancer metastasis. The review also discusses the role of various signaling pathways, including Ras, Rho, and Smad, in regulating EMT and the implications of EMT in fibrosis and cancer. Overall, EMT is a dynamic process that plays a critical role in tissue development, repair, and disease.